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Purpose: To elucidate the anatomical and visual outcomes of patients with idiopathic epiretinal
membranes (ERM) who underwent vitrectomy, membrane removal only, or with internal limiting
membrane (ILM) peeling under the assistance of different dyes.
Methods: A retrospective chart review of patients with idiopathic ERM who received surgical treatment
between January 2004 and December 2009. The patients were grouped according to the usage of staining
materials assisting ILM peeling. Group 1 consisted of 61 eyes that underwent conventional vitrectomy
and ERM peeling without staining-assisted ILM peeling. Group 2 consisted of 20 eyes with triamcinolone
acetonide-assisted ILM peeling following conventional vitrectomy. Group 3 consisted of 23 eyes with
indocyanine green-assisted ILM peeling following conventional vitrectomy.
Results: This study included 104 eyes from 104 patients. There was no signiﬁcant difference in age, sex,
preoperative visual acuity, retinal thickness or follow-up duration among the three groups. Overall, the
mean best-corrected visual acuity improved signiﬁcantly from baseline 0.15 to postoperative 0.41
(p< 0.0001). Among the three groups, the mean logarithm minimum angle of resolution acuity markedly
improved. There was no signiﬁcant difference in postoperative visual acuity among groups. As measured
by ocular coherent tomography, the mean central foveal thickness decreased from 465.21 86.18 to
299.16 70.14 mm. Although there was no difference between groups, postoperative retinal thickness
was thicker than that observed in the normal population. The incidence of recurrent ERM was 13.1% in
Group 1 and 0% in Groups 2 and 3; this incidence was signiﬁcantly higher than in the conventional
surgery group. Visual outcome was statistically more deteriorated in recurrent cases than in non-
recurrent cases (p¼ 0.011).
Conclusions: ERM surgeries with or without dye-assisted ILM peeling showed similar results. Moreover,
the incidence of recurrence is lower in the ILM peeling groups and plays a primary role in determining
the ﬁnal postoperative vision outcome.
Copyright  2012, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Epiretinal membranes (ERMs) typically affected patients older
than 50 years of age andmay be idiopathic or secondary to a variety
of ocular conditions.1,2 Idiopathic ERM have no obvious causes, and
patientsmay experience reduced visual acuity, metamorphopsia, or
micropsia as a result of macular edema and retinal traction. The
visual acuity may remain good, but most cases have slowly
progressive visual loss.3 The removal of epiretinal tissue haslogy, Chang Gung Memorial
aiwan.
e Ophthalmologic Society of Taiwbecome a standard procedure during vitrectomywhen the vision of
patients further deteriorates and necessitates surgical intervention.
Several reports have been published to describe visual outcomes
after the surgery.4,5
During the operation, the removal of ERM may be incomplete,
because it is difﬁcult to visualize the extent of the membrane if
ﬁbrosis or pigment deposition is not conspicuous. Inadvertent
trauma to the retina may therefore occur, in particular during
intentional internal limiting membrane (ILM) peeling for inexpe-
rienced surgeons.6,7 To overcome this challenging maneuver in
vitreoretinal surgery, the intraoperative application of materials
such as indocyanine green (ICG), trypan blue, and triamcinolone
acetonide (TA) to stain the membranes has become popular in
vitreoretinal surgery.8e10an. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Demographic characteristics and comparison of variables among participants.










Man 25 (41.0%) 8 (40.0%) 10 (43.5%) 0.971
Woman 36 (59.0%) 12 (60.0%) 13 (56.5%)
Mean SD Mean SD Mean SD
Age (y) 62.08 10.52 63.80 9.63 63.26 9.72 0.769
Follow-up (mo) 21.97 11.08 17.55 4.19 20.26 9.51 0.214
Pre-OP VA 0.14 0.11 0.21 0.18 0.14 0.10 0.113
Post-OP VA 0.39 0.28 0.41 0.27 0.49 0.35 0.383
Pre-OP CFT (mm) 462.70 83.90 470.30 87.34 467.43 94.56 0.935
Post-OP CFT (mm) 299.44 63.57 295.35 86.82 301.74 74.04 0.956
CFT¼ central foveal thickness; ICG¼ indocyanine green; NA¼ no staining applied;
OP¼ operation; SD¼ standard deviation; TA¼ triamcinolone acetonide; VA¼
visual acuity (Snellen equivalent).
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selectively stain the ERM and represent a contrast stain to assist in
membrane removal. Although several reports raised concern about
possible toxic effects on the retina in certain conditions,11,12 some
surgeons ﬁnd ICG staining of the ERM indispensable. Most surgeons
agree that there is a need for a safe and effective dye for staining
to facilitate membrane removal.13,14
TA, particularly with white specks and crystal deposits, was
introduced to help with membrane peeling under enhanced visi-
bility of both the ERM and ILM during membrane dissection.15
Although no clinical studies showed that TA was toxic to patients,
some experimental reports mentioned that TA might not be as safe
as originally used in vitrectomy.16
The comparison of safety between ICG and TA used in ERM
surgery with intentional ILM peeling has not beenwell discussed in
the literature. Its effect on anatomical and visual improvement has
not yet been thoroughly evaluated. Therefore, we performed
a large, consecutive case series of ERM patients undergoing surgical
intervention with the assistance of ICG or TA staining with or
without ILM peeling to investigate the factors contributing to ﬁnal
visual outcomes.
2. Materials and methods
A retrospective study was conducted by a chart review of all
patients with idiopathic ERM who underwent pars plana vitrec-
tomy and membrane peeling at Chang Gung Memorial Hospital,
Linkuo, Taoyuan between January 2004 and December 2009. The
study was approved by the Institutional Review Board of Chang
Gung Memorial Hospital in Taiwan. Eyes with idiopathic ERM with
vision deterioration that had undergone vitrectomy with ERM
removal were included. Due to the possibility of vision deteriora-
tion, eyes with a history of previous retinal surgery, retinal
detachment, diabetic retinopathy, retinal vascular occlusion,
uveitis, vitreous hemorrhage, trauma, ocular tumors, glaucoma,
optic atrophy, and corneal opacity were excluded. Patients with late
complications, such as retinal detachment, that would affect visual
acuity and require surgical intervention were also excluded.
Both inpatient and outpatient records were reviewed in detail.
The demographic data collected included the patient’s age, sex,
previous ocular history, and initial best-corrected visual acuity
(BCVA). Clinical manifestations, late complications, and ﬁnal BCVA
were also recorded. For statistical analysis, BCVA was converted to
the logarithm of the minimum angle of resolution (logMAR) for
calculation. Visual acuities of counting ﬁngers, hand motion, light
perception, and no light perception were assigned values of 1/200,
1/400, 1/800, and 1/1600, respectively.17 A thorough chart review
was performed to screen for patients with a minimum of 3 months
of follow-up.
Regarding the surgical procedure, a standard three-port pars
plana vitrectomy was performed in all patients using retrobulbar
anesthesia. Following core vitrectomy, an ERM within the vascular
arcade was then dissected from the retina. In some cases, the ERM
was removed without staining-assisted ILM peeling, and some
cases underwent ERM removal, followed by ILM peeling assisted by
ICG or TA staining. After the surgery, the retina was then inspected
(360) to determine if any tears had been intraoperatively created.
Laser photocoagulation was applied to the tears or lattice if
necessary. Intravitreal tamponade was not applied in these cases.
Overall, ocular ﬁndings of ERM include extending retinal folds,
distortion of the retinal vessels, and retinal edema. In this study, the
patients were grouped according to the staining materials used.
Group 1 comprised patients undergoing vitrectomy with ERM
removal alone and without staining-assisted ILM peeling. In Group
2, ICG was applied for staining before the membrane peeling. TheICG staining technique used was similar to that in previous publi-
cations. Brieﬂy, the membrane was stained in an air-ﬁlled vitreous
cavity, and ICGwas applied in 0.5 mg/ml for oneminute. In Group 3,
TAwas utilized to assist in the visualization of ERM and ILM peeling
during the procedure. In our study, the TA preservative was washed
out, and the membrane was stained with preservative-free TA
(a concentration of 20 mg/cc) in the ﬂuid-ﬁlled vitreous cavity.
To assay themorphology, retinal thickness weremeasured using
the Stratus OCT3 system (Stratus; Carl Zeiss Meditec, Dublin, CA). A
macular thickness map analysis program was used for the
measurements. In all measurements, retinal thickness and volu-
metric analyseswere performed in a circlewith a 1-mmdiameter in
the central macula. All the OCTmapswere checked for artifacts, and
themeasurements were repeated until high-quality measurements
could be achieved. According to Chan and colleagues,18 central
foveal thickness (CFT) is 182 23 mm in healthy eyes. CFT and ERM
recurrence were also observed during the follow-up period.
For analysis, abstracted data were entered into a Microsoft Excel
(Microsoft Corp., Redmond, WA, USA) spreadsheet and analyzed
using SPSS software (SPSS Inc., Chicago, IL, USA). Means, medians,
and standard deviations were then calculated as usual. We con-
ducted descriptive analysis and comparedvariables between groups
with and without staining using the analysis of variance method.
Visual outcomes and changes in macular thickness after surgery
were analyzed by using a paired t test. Furthermore, we evaluated
the differences between recurrent and non-recurrent participants.
A p< 0.05 was considered to be statistically signiﬁcant.
3. Results
A total of 104 consecutive patients (104 eyes) with idiopathic
ERM undergoing surgical treatment were retrospectively identi-
ﬁed. The mean age of all patients was 6710.06 (mean standard
deviation) years, and the follow-up period was 20.74 9.8 months.
In Group 1, 61 eyes underwent conventional vitrectomy with ERM
removal alone without ICG- or TA-assisted ILM peeling. In 20 eyes
from Group 2, TA without preservative was employed to assist in
the surgical procedures. In 23 eyes from Group 3, ICG (0.5 mg/ml)
was applied during surgery. Demographic characteristics for each
of these three groups are presented in Table 1. As can be seen, there
is no signiﬁcant difference in gender, age, baseline BCVA or CFT
among the participants.
Comparing the ﬁnal visual outcome of all three groups revealed
no statistically signiﬁcant difference in postoperative BCVA
(Table 1). In addition, for all 104 ERM patients, vision improved
from 0.15 to 0.41 (Snellen equivalent) after vitrectomy with ERM
removal (p< 0.0001). These results are shown in Table 2. In other
Table 2
Postoperation visual improvement and macular edema resolution.
Preoperation VA Postoperation VA p value
(paired t test)
Total 0.15 0.13 0.41 0.29 <0.0001*
NA (n¼ 61) 0.14 0.11 0.39 0.28 <0.0001*
TA (n¼ 20) 0.21 0.18 0.41 0.28 0.001*
ICG (n ¼23) 0.14 0.10 0.49 0.35 <0.0001*
Preoperation CFT Postoperation CFT
Total 465.21 86.18 299.16 70.14 <0.0001*
NA (n¼ 61) 462.70 83.90 299.44 63.57 <0.0001*
TA (n¼ 20) 470.30 87.34 295.35 86.82 <0.0001*
ICG (n¼ 23) 467.43 94.56 301.70 74.04 <0.0001*
CFT¼ central foveal thickness; ICG¼ indocyanine green; NA¼ no staining applied;
TA¼ triamcinolone acetonide; VA¼ visual acuity.
*p value & 0.001.
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(p< 0.05) after surgical intervention and comparable ﬁnal visual
outcomes of ERM surgery performed with or without staining-
assisted ILM peeling.
As for anatomic evaluation, the CFT was measured before and
after ERM surgery. The results are listed in Table 1. In general, the
thickness decreased from 465.2186.18 to 299.16 70.14 mm after
the surgery. There was no difference between pre- and post-
operative CFT in each group. Furthermore, the mean postoperative
retinal thickness of all eyes was still thicker than that of the normal
population (Table 2).
Overall, recurrent ERM was documented in eight out of 104
cases (7.7%) in our study. Among the three groups, the incidence of
recurrence was signiﬁcantly higher in Group 1, and there was no
recurrence in Group 2 or 3. Further analysis also showed that the
recurrent cases had signiﬁcantly poorer postoperative vision than
the nonrecurrent cases [logMAR (Snellen equivalent) 0.87 0.34
(0.18 0.13) vs. 0.50 0.39 (0.43 0.30), p¼ 0.011]. These results
are shown in Table 3.
4. Discussion
For macular ERM, vitrectomy with ERM peeling can effectively
relieve traction to the retina, thus improving vision and decreasing
metamorphopsia.4,5,19 To facilitate visualization of the epiretinal
membrane and ILM peeling, we used staining materials including
ICG and TA to assist in peeling the membranes and prevent
potential damage to the retina. To our knowledge, ICG had been
widely employed to enhance the visualization of ILM during
macular pucker and macular hole surgery.20,21 Nevertheless, the
toxic effects of ICG on retinal pigment epithelium and retinal
ganglion cell were shown to be time- and dose-dependent in cell
culture studies.11,12 Particularly in macular pucker cases, HaritoglouTable 3







Group 1 NA, [No (%)] 8 (100) 53 (55.2)
Group 2 TA, [No (%)] 0 20 (20.8) 0.047*








Post-OP CFT (mm) 325.13 65.73 290.00 70.39 0.279
Data are shown as mean standard deviation. Chi-square test for staining groups,
independent sample test for post-OP VA and thickness.
*p< 0.05.
CFT¼ central foveal thickness; ICG¼ indocyanine green; logMAR¼ logarithm of the
minimum angle of resolution; NA¼ no staining material applied; OP¼ operative;
TA¼ triamcinolone acetonide; VA¼ visual acuity.and colleagues8 revealed possible adverse events of the dye in
individuals with more cellular debris on the retina as well as on
functional outcomes in patients with large visual ﬁeld defects after
ICG-assisted ILM peeling.
Owing to the concern in recent reports regarding the safety of
vital dyes such as ICG and TB, TA was expected to be an alternative
to ICG in ILM peeling during macular hole surgery.22 TA had also
been employed to enhance visualization and to identify the
vitreous cortex during vitrectomy in proliferative vitreoretinop-
athy.23,24 Although there is concern regarding possible toxicity to
the retinal vessels,16 TA is cost effective in clinical use. By contrast to
ICG, TA does not possess photosensitizing properties and will not
have phototoxic effects on the retina. In addition, TA does not really
stain the ILM like other dyes; it only covers the surface of the ILM.
This characteristic allows TA to be easily removed after the surgery
and reduces the potential toxic effect of long-term retention as is
typically observed after the application of ICG. The best way to
prevent the potential toxic effect of TA to the retina and RPE is to
reduce the accumulation of TA on the retina. However, ILMmay not
be removed completely after ERM removal due to the difﬁculty of
ILM identiﬁcation.25
Our results showed that most patients with idiopathic ERM
experienced substantial visual improvement after vitrectomy and
membrane peeling. The visual recovery result was consistent with
that achieved byother conventional ERM surgerieswithout staining
or intentional ILM peeling.26,27 Moreover, we found no signiﬁcant
difference in postoperative visual acuity betweenpatientswith ICG-
or TA-assisted ILM peeling as compared with those undergoing
vitrectomy and ERM peeling alone. The higher rate of recurrent
pucker observed in Group 1 may have resulted from incomplete
removal of the ILM.28 Park and coworkers26 reported 21% recurrent
macular pucker or persistent contraction to the ILM without ILM
peeling or staining assistance in ERM surgery. In our study, the
incidence of recurrence was signiﬁcantly lower in the staining-
assisted groups than in the conventional surgery group without
ILM peeling. Furthermore, as the literature on the recurrence rate of
conventional surgery without ILM peeling is scarce, our retrospec-
tive comparison between ILM peeling with the use of various dyes
and conventional ERM surgery demonstrated comparable visual
outcome and lower recurrence following ICG- or TA-assisted ILM
peeling. As seen in our OCT measurements, retinal thickness
decreased signiﬁcantly after surgery. However, the postoperative
retinal thickness was still thicker than that of the normal pop-
ulation. Okamoto and others29 demonstrated a signiﬁcant correla-
tion between postoperative vision-related quality of life and degree
of postoperative metamorphopsia. Indeed, our results showed
deterioration in postoperative vision in recurrent ERM. To our
knowledge, this is the ﬁrst study comparing the results of different
staining-assisted ERM surgeries. This retrospective study also had
several limitations. The number of study patients was small, and the
follow-up periods also varied in length. The lens status in each
patient differed, and visual acuities were not measured with early
treatment of diabetic retinopathy study (ETDRS) charts.
In conclusion, the postoperative vision of idiopathic ERM
improved signiﬁcantly. ERM surgeries with or without dye-assisted
ILM peeling showed similar results. The recurrence of ERM played
the main role in determining the ﬁnal visual outcome.References
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